Stock Forecast

  Aesthetic Medical International Holdings Group Limited ( AIH) Stock. Should you Buy or Sell?    $ 1.86

0.14 (7.00 %)



Aesthetic Medical International Holdings Group Limited Analysis

Updated on 10-09-2022
Symbol AIH
Price $1.86
Beta -0.472
Volume Avg. $13.71 thousand
Market Cap $58.28 M
52 Week Range $1.17 - $4.64


Aesthetic Medical International Holdings Group Limited opened the day at $1.86 which is +'7.00 % on yesterday's close. Aesthetic Medical International Holdings Group Limited has a 52 week high of $4.64 and 52 week low of $1.17, which is a difference of $3.47. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $58.28 M and total net profit is $645593000 which means the company is trading at 0.09 times profit to market capitalization. Theoretically, if you were to buy Aesthetic Medical International Holdings Group Limited for $58.28 M, it would take 15 years to get your money back. Aesthetic Medical International Holdings Group Limited are in the Medical Care Facilities space which will have a sweet spot and industry standard for net profit multiples.



Price Chart


1 D | All


Financials




Aesthetic Medical International Holdings Group Limited Stock Forecast - Is Aesthetic Medical International Holdings Group Limited a Buy or Sell?


DCF ScoreStrong Buy
ROE ScoreNeutral
ROA ScoreNeutral
DE ScoreStrong Buy
PE ScoreStrong Sell
PB ScoreStrong Buy
Overall RecommendationBuy

Growth and Value


PE Ratio -0.971
Dividend Yiel 0.000
Net Profit Margin -0.349


Valuing Aesthetic Medical International Holdings Group Limited


Price Book Value Ratio -1.732 Price To Book Ratio -1.732
Price To Sales Ratio 0.339 Price Earnings Ratio -0.971


How liquid is Aesthetic Medical International Holdings Group Limited


Current Ratio 0.190
Quick Ratio 0.135


Debt


Debt Ratio 1.317 Debt Equity Ratio -4.961
Long Term Debt To Capitalization 3.078 Total Debt To Capitalization 1.562



Latest news about Aesthetic Medical International Holdings Group Limited


Aesthetic Medical International Holdings Group Limited (AIH) CEO Pengwu Zhou on Q2 2022 Results - Earnings Call Transcript

Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH ) Q2 2022 Earnings Conference Call August 17, 2022 8:00 AM ET Company Participants Pengwu Zhou - Chairman & Chief Executive Officer Derrick Chi - Investor Relations Associate Director Toby Wu - Chief Financial Officer Conference Call Participants Operator Good morning, ladies and gentlemen. Thank you for standing by and welcome to Aesthetic Medical International First Half of 2022 Earnings Conference Call.

Date : 17/08/2022

Aesthetic Medical International to Announce Unaudited Financial Results for the First Half of 2022 on August 17, 2022

SHENZHEN, China, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it will release its unaudited financial results for the first half of 2022 before the U.S. market opens on Wednesday, August 17, 2022.

Date : 10/08/2022

Aesthetic Medical International Holdings Group Limited (AIH) CEO Dr. Pengwu Zhou on Q2 2021 Results - Earnings Call Transcript

Aesthetic Medical International Holdings Group Limited (AIH) CEO Dr. Pengwu Zhou on Q2 2021 Results - Earnings Call Transcript

Date : 16/11/2021

Aesthetic Medical International to Announce Unaudited Financial Results for the Second Quarter and First Half of 2021 on November 16, 2021

SHENZHEN, China, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it will release its unaudited financial results for the second quarter and first half of 2021 before the U.S. market opens on Tuesday, November 16, 2021.

Date : 08/11/2021

Aesthetic Medical International Announces Restructuring Plans to Optimize Business Operations

SHENZHEN, China, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced a preliminary plan for business strategies and restructuring. In light of the time and efforts needed to assess the impact of such plan on its financial results, the Company currently anticipates that the release of its unaudited financial results for the three months and six months ended June 30, 2021 will be delayed.

Date : 30/09/2021





About Aesthetic Medical International Holdings Group Limited


CEO : Dr. Pengwu Zhou
Sector : Healthcare
Industry : Medical Care Facilities

Website : https://ir.aihgroup.net

Exchange : NASDAQ Global Market

Description :

Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. It operates 15 treatment centers in China, Hong Kong, and Singapore. Aesthetic Medical International Holdings Group Limited was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.


My Newsletter

Sign Up For Updates & Newsletters